Australia markets closed

Imugene Limited (IMU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0790-0.0040 (-4.82%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
30,865
30,865
36,612
15,355
9,364
Selling general and administrative
18,272
18,272
12,432
9,593
4,576
Total operating expenses
51,293
51,293
50,673
25,666
14,879
Operating income or loss
-51,293
-51,293
-50,673
-25,666
-14,879
Interest expense
-
-
106.744
111.032
5.029
Total other income/expenses net
11,526
11,526
12,732
7,200
4,074
Income before tax
-37,915
-37,915
-37,869
-18,455
-10,508
Income tax expense
0
0
0
0
0
Income from continuing operations
-37,915
-37,915
-37,869
-18,455
-10,508
Net income
-37,915
-37,915
-37,869
-18,455
-10,508
Net income available to common shareholders
-37,915
-37,915
-37,869
-18,455
-10,508
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.00
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.00
Basic average shares
6,275,676
6,317,916
5,637,197
4,663,541
4,074,894
Diluted average shares
6,275,676
6,317,916
5,637,197
4,663,541
4,074,894